Two Years In: An Inside Look at COVID-19 Relief Fraud and What to Expect Next

14 Feb 2022

COVID-19 is one of the most significant public health and economic crises in modern history and has since presented myriad challenges to both our professional and personal lives. The U.S. government stepped in with various relief programs, some wildly successful and others less popular, but all of which present the potential for fraud. While fraud enforcement was not initially front and center, now, after two years, the U.S. government has dedicated resources and regulatory frameworks to combat COVID-19 relief fraud, and companies must be prepared for a heightened wave of enforcement.

Morrison & Foerster’s team includes former government officials from the U.S. Department of Justice (DOJ), U.S. Securities and Exchange Commission (SEC), and U.S. Food & Drug Administration (FDA), among other government agencies, who regularly advise companies on a wide variety of regulatory, enforcement, and investigative matters. Utilizing this experience, our team will provide first-hand insights on U.S. government resources and regulatory frameworks to be aware of, which can help mitigate potential disputes and regulatory inquiries as we continue to navigate the ever-changing legal landscape surrounding the ongoing COVID-19 pandemic.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.